Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Advanced Technology Co KSCCKUW:ATC -1.80%18 Debt-to-EBITDA is 118.91 as of Mar. 2026, which is 1217% above its 10-year median of 9.03. GuruFocus rates KUW:ATC with a GF Score™ of 18/100 and a GF Value™ of KWD0.35 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 91 Medical Distribution companies, Advanced Technology Co KSCC ranks worse than 100% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Advanced Technology Co KSCC's Debt-to-EBITDA or its related term are showing as below:
KUW:ATC'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 5.35 Med: 9.03 Max: 478.98
Current: 478.98
During the past 13 years, the highest Debt-to-EBITDA Ratio of Advanced Technology Co KSCC was 478.98. The lowest was 5.35. And the median was 9.03.
KUW:ATC's Debt-to-EBITDA is ranked worse than 100% of 91
companies
in the Medical Distribution industry
Industry Median: 2.32
vs KUW:ATC: 478.98
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Advanced Technology Co KSCC Debt-to-EBITDA Related Terms
Advanced Technology Co KSCC Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KUW:ATC vs MCK, COR, CAH: Debt-to-EBITDA Comparison
For the Medical Distribution subindustry, Advanced Technology Co KSCC's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Technology Co KSCC Debt-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Advanced Technology Co KSCC's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Advanced Technology Co KSCC's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Advanced Technology Co KSCC (KUW:ATC) has a Debt-to-EBITDA of 118.91 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Advanced Technology Co KSCC. This is 1217% above median its historical median of 9.03. Over the past decade, Advanced Technology Co KSCC's Debt-to-EBITDA has ranged from 5.35 to 478.98. According to the industry distribution chart, Advanced Technology Co KSCC ranks #91 out of 91 companies in the Medical Distribution industry.
Is Advanced Technology Co KSCC's Debt-to-EBITDA too high?
Advanced Technology Co KSCC's current Debt-to-EBITDA of 118.91 is 1217% above median its 10-year median of 9.03. Over the past 10 years, this metric has ranged from a low of 5.35 to a high of 478.98. The Medical Distribution industry median Debt-to-EBITDA is 2.32. Advanced Technology Co KSCC's value of 118.91 is 5025.4% above this industry median. Based on the distribution chart, Advanced Technology Co KSCC ranks #91 out of 91 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Advanced Technology Co KSCC has a GF Score™ of 18/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Technology Co KSCC's Debt-to-EBITDA compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Advanced Technology Co KSCC ranks #91 out of 91 companies for Debt-to-EBITDA. This places Advanced Technology Co KSCC in the lower half of its industry. The industry median Debt-to-EBITDA is 2.32. Advanced Technology Co KSCC's value of 118.91 is 5025.4% above this benchmark. Historically, Advanced Technology Co KSCC's own Debt-to-EBITDA has ranged from 5.35 to 478.98 over the past decade. While the company's 10-year median is 9.03 vs. the industry median of 2.32, Advanced Technology Co KSCC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Distribution company?
The median Debt-to-EBITDA among Medical Distribution companies is 2.32, based on 91 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Technology Co KSCC's current Debt-to-EBITDA of 118.91 is 5025.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Advanced Technology Co KSCC. For the Medical Distribution industry, the median Debt-to-EBITDA is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Technology Co KSCC's current Debt-to-EBITDA is 118.91, which is 1217% above median its own 10-year median of 9.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Technology Co KSCC stock overvalued right now?
Based on GuruFocus' analysis, Advanced Technology Co KSCC (KUW:ATC) is currently considered Significantly Overvalued. The stock's GF Value™ is KWD0.35, compared to a current price of KWD0.55 — trading 55.7% above its estimated fair value. The current Debt-to-EBITDA is 118.91, which is 1217% above median its 10-year median of 9.03 and 5025.4% above the Medical Distribution industry median of 2.32. Advanced Technology Co KSCC's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Advanced Technology Co KSCC (KUW:ATC), the current Debt-to-EBITDA is 118.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Technology Co KSCC (KUW:ATC) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Technology Co KSCC stock appears to be overvalued.
The current stock price of KWD0.55 is trading 55.7% above its estimated GF Value™ of KWD0.35.
GuruFocus considers Advanced Technology Co KSCC to be Significantly Overvalued.
Key valuation signals for KUW:ATC:
Debt-to-EBITDA: 118.91 (1217% above median its 10-year median of 9.03)
GF Value™: KWD0.35 vs. price of KWD0.55 (55.7% above fair value)
Industry Position: 5025.4% above the Medical Distribution median (#91 of 91)
No single metric tells the full story. See the KUW:ATC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Technology Co KSCC is a medical equipment supplier to the Kuwait healthcare sector. Some of the services provided by the company are - Diagnostic imaging, Laboratory environmental management and Automation, Medical & surgical O.R solutions, Healthcare manpower services, and more. The company has two main business segment i.e. supply of medical goods and maintenance services and provision of healthcare services. also engages in constructing, managing, and possessing hospitals, medical centers, clinics, and specialized labs. In addition, the firm offers a pharmacy license, and home care services.
18GF Score
Get the complete analysis for KUW:ATC
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KUW:ATC has been successfully added to your 
